Howard Financial Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
AAMU
AIM
AV
MIF
ZIC
Howard Financial Services's AZN Position: Q2 2026 in Review
Howard Financial Services opened a new position in AstraZeneca (AZN) in Q2 2026: 2,120 shares worth $402K. The stake represents 0.04% of the portfolio and ranks #163 among its holdings. This is a return to the name: Howard Financial Services previously reported a position in AZN as recently as Q4 2025.
Howard Financial Services first reported a position in AZN in Q2 2022 and has held it in 16 quarters since. The position peaked at $585K in Q2 2023. 419 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Howard Financial Services held 2,120 shares of AstraZeneca worth $402K as of Q2 2026.
- AstraZeneca was a new Howard Financial Services position in Q2 2026.
- AstraZeneca made up 0.04% of Howard Financial Services's portfolio in Q2 2026, its #163 holding.
- Howard Financial Services first reported a position in AstraZeneca in Q2 2022 and has held it in 16 quarters since.
- Howard Financial Services's AstraZeneca position peaked at $585K in Q2 2023.
- 419 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Howard Financial Services's 13F filing for Q2 2026, filed 7 Jul 2026.